How Often Do I Take NRTIs

Here's a taste of what TheBody.com has to offer on this topic:

Ask the Experts

Off label use of NRTIs for obesity

Hi there doctor,Thanks for this fantastic web site and the work you do.Out of curosity, with the focus on NRTIs, esp. the D-drugs and azt on fat loss, has there been any discussion of using this category of drugs off-label to treat obese or...

Response from Keith Henry, M.D.

University of Minnesota, School of Medicine

NRTIs are generally expensive with a wide range of potential mild or serious side effects. The effect on fat resulting in fat loss is believed to be due partly to fat cell death possibly linked to mitochondrial toxicity which has potentially serious... Read more »

Resitant to all PIs & almost all NRTIs

Hello,I have been HIV+ for 25 years and have done pretty well on my HIV therapies which I began... Read more »

Response from Renslow Sherer, M.D. »

Sustiva causing resistance to other nNRTIs

Sustiva (efavirenz)-Induced Mutation in Subtype C HIV May Confer Multi-NNRTI ResistanceA mutation... Read more »

Response from Benjamin Young, M.D., Ph.D. »

Go to Ask the Experts »

Articles

Know Your HIV Drugs: NRTIs (The Nukes)

In recent years the drug choices available to people with HIV have increased substantially. There are currently 16 approved antiviral drugs for HIV and these drugs are usually used in combinations of three or more to create an effective antiviral... Read more »

Nukes? Or No Nukes?

While specific drugs have fallen in and out of favor, the basic structure of anti-HIV therapy -- called HAART -- has changed very little since the late 1990s. Almost all regimens include one highly potent drug -- either a boosted protease inhibitor... Read more »

U.S. Centers for Disease Control and Prevention

AIDS Drugs Can Cause Premature Aging: Study

A class of AIDS drugs has been linked with mitochondrial DNA mutations, which could help explain the premature aging and age-related illnesses seen in some HIV patients, British researchers say in a new study. The implicated class, nucleoside analog... Read more »

Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

A regimen of either efavirenz or lopinavir-ritonavir plus two nucleoside reverse-transcriptase inhibitors (NRTIs) is recommended for HIV-1 patients starting initial therapy; however, it is not known which of these two regimens has greater efficacy.... Read more »

Connect With Others

Drug Resistant HIV

Posted by Anonymous

Hi

I just found out the strain of hiv i have is resistant to possibly a whole class of NRTIs and PIs..any experience with this for any of you? what could the options be for someone in my situation? I am still treatment naive.

Read more »

Picking treatment

Posted by Anonymous, 3 Replies

I have to pick my treatment now (positive for 8 years and only now do I need treatment cause viral load went up and tcells went down)and I'm not sure what to do. Any suggestions for first choice of therapy...I heard sustiva with two nrtis would be... Read more »

Entry Inhibitors

Posted by Anonymous, 1 Reply

Does anyone know anything about the new entry inhibitors? I think Pfizer and Schering both have drugs in development. Should we be hopeful? Read more »

want to have a baby, but worried

Posted by kolo, 1 Reply

quote: Adam Legge, Monday, April 16, 2007
Antiretroviral drugs used to prevent HIV transmission from mother to child can cause genetic damage in infants that may increase their risk of developing cancer in the future, according to new research.

The... Read more »

Connect on Our Bulletin Boards »

Tools

My Health Tracker

Assess Your Risk for HIV

Find Local HIV/AIDS Services

Resource Centers

Guides for People With HIV

View All of Our Guides >>

Related Topics

View More HIV/AIDS-Related Topics »

The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.